Clinical Trial Update: Testosterone Treatment in a Patient With 17β-hydroxysteroid Dehydrogenase Type 3 Deficiency: an N-of-1 Study [Phase 3]

View source ↗

Summary

An N-of-1 Phase 3 trial evaluating testosterone treatment in a patient with 17β-hydroxysteroid dehydrogenase type 3 deficiency. The study status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Disorder of Sex Development 46 Xy

Drugs mentioned

• TESTOSTERONE (testosterone)

Snippet

Sponsor: Erasmus Medical Center | Conditions: Disorder of Sex Development, 46,XY | Phase 3 | Status: UNKNOWN